Author: Gabriel

05

May | 2022

CNBX Pharmaceuticals Granted Patent in Hong Kong

TEL AVIV, Israel and BETHESDA, Md., May 5, 2022  CNBX Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannab

28

March | 2022

Cannabics Pharmaceuticals Changes Name to CNBX Pharmaceuticals

TEL AVIV, Israel and BETHESDA, Md., March 28, 2022 Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer relate